As of 6 Nov 2026, Global Longlife Hospital and Research is loss-making on a trailing 12-month basis, with a net loss of ₹1.72 Cr, so it has no P/E ratio. The share price is ₹14.45, 44% below its 52-week high. It is listed on an SME platform with a market cap of ₹15 Cr, ranked 36th of 40 Medical Care Facilities companies by market cap; the shares fell 41% over the past year.
- ₹13.55
- ₹14.66
- ₹13.55
- ₹13.98
- 1.1 L
Health check
- ReturnsBehind
−41.1% over a year, better than 0 of 7 peers.
- Price tagLoss-making
Earnings were negative over the last 12 months.
- Growthn/a
Not enough yearly results to measure.
- ProfitabilityNegative
ROCE -4.2% vs peer median 11.9%.
- Balance sheetn/a
Balance sheet figures aren’t reported.
- Red flags4 to check
Loss-making over the last twelve months.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹15 Cr
- Small cap
- P/E
- n/a
- Industry 47.7
- Price to book
- 0.64
- Peers 8.06
- Dividend yield
- 0.00%
- ROE
- −6.8%
- Peers 12.8%
- ROCE
- −4.2%
- Peers 11.9%
- Debt to equity
- n/a
- Debt ₹0.00 Cr
- EPS (TTM)
- −₹1.64
- OPM (TTM)
- −19094.2%
- Net margin 0.0%
- Sales growth
- n/a
- Year-ago quarter not reported
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- 2917.79
- EV/EBITDA 4.6
Strengths and risks
Risks to check
- Loss-making over the last twelve months.
- Return on equity is low at −6.8%.
- 44% below its 52-week high.
- Interest coverage of only −3309.7×.
About Global Longlife Hospital and Research
Global Longlife Hospital and Research Limited, a multi-speciality tertiary care hospital, provides medical and surgical specialities services in India. It offers medical services, such as oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anaesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, GI medicine, gynecology, infectious disease, nephrology, and neurology; and surgical services, including…
- Headquarters
- Ahmedabad
- Employees
- 3
- Sector
- Healthcare
- ISIN
- INE0J2K01014
- Website
- globalhospital.co.in
Price range
- Avg volume (3M)
- 1.4 L
- 1-year return
- minus 41.1%
- From 52-week high
- minus 44.0%
Peers · Medical Care Facilities
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSPApollo Hospitals Enterprise | 8,446.00 | plus 0.90% | 1,21,441 | 54.0 | 11.45 | 19.2% | 22.5% | 15.4% | 14.8% | 33.3% | 0.24% | plus 7.2% |
| MAXHEALTHMax Healthcare Institute | 934.00 | plus 0.21% | 90,909 | 66.1 | 8.03 | 12.6% | 12.8% | 26.8% | 22.4% | 9.3% | 0.21% | minus 18.1% |
| MANIPALHOSManipal Health Enterprises | 646.70 | minus 1.61% | 85,065 | 133.6 | 9.05 | 9.8% | 9.2% | 17.8% | – | – | 0.00% | minus 3.0% |
| ASTERDMAster DM Quality Care | 713.15 | minus 0.89% | 62,092 | 90.7 | 8.06 | 9.4% | 9.7% | 17.4% | 15.7% | −3.0% | 0.42% | plus 4.5% |
| FORTISFortis Healthcare | 766.90 | minus 6.45% | 57,898 | 55.7 | 5.52 | 11.9% | 10.4% | 22.2% | 13.3% | 20.9% | 0.13% | minus 19.6% |
| NHNarayana Hrudayalaya | 1,903.00 | minus 0.65% | 38,650 | 44.7 | 7.73 | 11.4% | 19.1% | 18.5% | 20.5% | 9.9% | 0.24% | plus 4.7% |
| MEDANTAGlobal Health | 1,387.60 | minus 0.15% | 37,264 | 60.4 | 8.63 | 15.0% | 15.2% | 22.1% | 17.2% | 19.5% | 0.04% | plus 11.2% |
| GLHRLGlobal Longlife Hospital and Research | 14.45 | plus 3.36% | 15 | – | 0.64 | −4.2% | −6.8% | −19094.2% | – | – | 0.00% | minus 41.1% |
| Median of 7 peers | – | −0.65% | 62,092 | 60.4 | 8.06 | 11.9% | 12.8% | 18.5% | 16.5% | 14.7% | 0.21% | 4.5% |
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
- ROE
- −6.8%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 23.5 | 13.5 | 0.6 | – | |
| – | minus 42.5% | minus 95.7% | – | |
| 19.4 | 13.8 | 4.7 | – | |
| 4.1 | −0.2 | −4.2 | −1 | |
| 17.3% | −1.8% | −720.4% | – | |
| 0 | −0 | 5 | 0 | |
| 0.3 | 0.7 | 0.3 | 0 | |
| 1.2 | 1.3 | 0.5 | – | |
| 0.1 | −0.1 | – | – | |
| 2.7 | −2.3 | 0.1 | −1 | |
| 32.5% | 3.4% | −100.3% | −74.0% | |
| 1.8 | −2.2 | 0.2 | −1.7 | |
| – | minus 219.7% | – | minus 965.4% | |
| 1.79 | -2.08 | 0.19 | – |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 10.5 | 10.5 | 10.5 | 10.5 | |
| 53.8 | 15.4 | 16.3 | 13.2 | |
| 9.3 | 12.7 | – | – | |
| 2.4 | 3.1 | 0.1 | 0 | |
| 75.9 | 41.7 | 26.8 | 23.8 | |
| 17.5 | 17.3 | – | – | |
| 1 | – | – | – | |
| 0.1 | 0 | 0 | – | |
| 3.7 | 0.4 | 21.5 | 17 | |
| 53.5 | 24 | 5.3 | 6.7 | |
| 75.9 | 41.7 | 26.8 | 23.8 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| −40.4 | −5.1 | 12.3 | −4.5 | |
| −1.9 | −0.8 | 21.8 | 0 | |
| 45.7 | 2.7 | −13 | −0 | |
| 3.4 | −3.2 | 21.1 | −4.5 | |
| −2 | −1 | −0.1 | – | |
| −42.4 | −6.1 | 12.2 | −4.5 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.